1. Redline RW, Heller D, Keating S, Kingdom J. Placental diagnostic criteria and clinical correlation–a workshop report. Placenta. 2005; 26(Suppl A):S114–7.
2. Perrone S, Toti P, Toti MS, Badii S, Becucci E, Gatti MG, et al. Perinatal outcome and placental histological characteristics: a single-center study. J Matern Fetal Neonatal Med. 2012; 25(Suppl 1):110–3.
Article
3. Dammann O, Brinkhaus MJ, Bartels DB, Dordelmann M, Dressler F, Kerk J, et al. Immaturity, perinatal inflammation, and retinopathy of prematurity: a multi-hit hypothesis. Early Hum Dev. 2009; 85:325–9.
Article
4. Hartling L, Liang YY, Lacaze-Masmonteil T. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and metaanalysis. Arch Dis Child Fetal Neonatal Ed. 2012; 97:F8–17.
Article
5. Mitra S, Aune D, Speer CP, Saugstad OD. Chorioamnionitis as a Risk Factor for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis. Neonatology. 2014; 105:189–99.
Article
6. Wu YW, Colford JM Jr. Chorioamnionitis as a risk factor for cerebral palsy: A metaanalysis. JAMA. 2000; 284:1417–24.
Article
7. Wu YW, Escobar GJ, Grether JK, Croen LA, Greene JD, Newman TB. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA. 2003; 290:2677–84.
Article
8. Suppiej A, Franzoi M, Vedovato S, Marucco A, Chiarelli S, Zanardo V. Neurodevelopmental outcome in preterm histological chorioamnionitis. Early Hum Dev. 2009; 85:187–9.
Article
9. Rovira N, Alarcon A, Iriondo M, Ibanez M, Poo P, Cusi V, et al. Impact of histological chorioamnionitis, funisitis and clinical chorioamnionitis on neurodevelopmental outcome of preterm infants. Early Human Dev. 2011; 87:253–7.
Article
10. Andrews WW CS, Biasini F, Peralta-Carcelen AM, Rector R, Alriksson-Schmidt Al. Early preterm birth: association between in utero exposure to acute inflammation and severe neurodevelopmental disability at 6 years of age. Am J Obstet Gynecol. 2008; 198:446.e1–11.
11. Mu SC, Lin CH, Sung TC, Chen YL, Lin YC, Lee CC, et al. Neurodevelopmental outcome of very-low-birthweight infants with chorioamnionitis. Acta paediatr Taiwan. 2007; 48:207–12.
12. Polam S, Koons A, Anwar M, Shen-Schwarz S, Hegyi T. Effect of chorioamnionitis on neurodevelopmental outcome in preterm infants. Pediatr Adolesc Med. 2005; 159:1032–5.
Article
13. Oqunyemi D MM, Jackson U, Hunter N, Alperson B. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonatal Med. 2003; 13:102–9.
14. van Vliet EOG, de Kieviet JF, van der Voorn JP, Been JV, Oosterlaan J, van Elburg RM. Placental pathology and longterm neurodevelopment of very preterm infants. Am J Obstet Gynecol. 2012; 206:489.e1–7.
Article
15. Parra-Saavedra M CF, Triunfo S, Savchev S, Pequero A, Nadal A, et al. Neurodevelopmental outcome of near-term small-for-gestational-age infants with and without signs of placental underperfusion. Placenta. 2014; 35:269–74.
16. Son SH, Choi KY, Lee JM, Shin SH, Kim C, Kim YJ, et al. Comparison of the incidences of neonatal morbidities by different criteria of histologic chorioamnionitis in extremely low gestational age newborns. Neontal Med. 2013; 20:35–41.
Article
17. Yoo C, Jang DG, Jo YS, Yoo J, Lee G. Pathologic differences between placentas from intrauterine growth restriction pregnancies with and without absent or reveresed end diastolic velocity of umbilical arteries Korean J Pathol. 2011; 45:36–44.
18. Fenton TR. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC pediatr. 2003; 3:13.
Article
19. Sankilampi U, Hannila ML, Saari A, Gissler M, Dunkel L. New population-based references for birth weight, length, and head circumference in singletons and twins from 23 to 43 gestation weeks. Ann Med. 2013; 45:446–54.
Article
20. Bell MJ TJ, Feigin RD, Keating JP, Marshall R, Barton L. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978; 187:1–7.
21. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978; 92:529–34.
Article
22. Jobe AH, Ikegami M. Prevention of bronchopulmonary dysplasia. Curr Opin Pediatr. 2001; 13:124–9.
Article
23. Almog B, Shehata F, Aljabri S, Levin I, Shalom-Paz E, Shrim A. Placenta weight percentile curves for singleton and twins deliveries. Placenta. 2011; 32:58–62.
Article
24. Goldenberg RL, Andrews WW, Hauth JC. Choriodecidual infection and preterm birth. Nutr Rev. 2002; 60:S19–25.
Article
25. Kovo M, Schreiber L, Ben-Haroush A, Wand S, Golan A, Bar J. Placental vascular lesion differences in pregnancy-induced hypertension and normotensive fetal growth restriction. Am J Obstet Gynecol. 2010; 202:561.e1–5.
Article
26. Aviram R, T BS, Kidron D. Placental aetiologies of foetal growth restriction: clinical and pathological differences. Early Hum Dev. 2010; 86:59–63.
Article
27. Vedmedovska N, Rezeberga D, Teibe U, Melderis I, Donders GG. Placental pathology in fetal growth restriction. Eur J Obst Gynecol Reprod Biol. 2011; 155:36–40.
Article
28. Rakza T, Magnenant E, Klosowski S, Tourneux P, Bachiri A, Storme L. Early hemodynamic consequences of patent ductus arteriosus in preterm infants with intrauterine growth restriction. J Pediatr. 2007; 151:624–8.
Article
29. Been JV, Lievense S, Zimmermann LJI, Kramer BW, Wolfs TGAM. Chorioamnionitis as a risk factor for necrotizing enterocolitis: A systematic review and metaanalysis. J Pediatr. 2013; 162:236–42.e2.
30. Rezaie P, Dean A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology. 2002; 22:106–32.
Article
31. Savchev S, Sanz-Cortes M, Cruz-Martinez R, Arranz A, Botet F, Gratacos E, et al. Neurodevelopmental outcome of fullterm small-for-gestational-age infants with normal placental function. Ultrasound Obstet Gynecol. 2013; 42:201–6.
Article
32. Gavilanes AW, Strackx E, Kramer BW, Gantert M, Van den Hove D, Steinbusch H, et al. Chorioamnionitis induced by intraamniotic lipopolysaccharide resulted in an interval-dependent increase in central nervous system injury in the fetal sheep. Am J Obstet Gynecol. 2009; 200:437.e1–8.
Article
33. Feldhaus B, Dietzel ID, Heumann R, Berger R. Effects of interferon-gamma and tumor necrosis factor-alpha on survival and differentiation of oligodendrocyte progenitors. J Soc Gynecol Investig. 2004; 11:89–96.
34. Burd I, Balakrishnan B, Kannan S. Models of fetal brain injury, intrauterine inflammation, and preterm birth. Am J Reprod Immunol. 2012; 67:287–94.
Article
35. Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I, et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Nurosci. 2006; 26:4752–62.
Article
36. Redline R, Minich N, Taylor HG, Hack M. Placental lesions as predictors of cerebral palsy and abnormal neurocognitive function at school age in extremely low birth weight infants (<1 kg). Pediatr Dev Pathol. 2007; 10:282–92.
37. Nasef N, Shabaan AE, Schurr P, Iaboni D, Choudhury J, Church P, et al. Effect of clinical and histological chorioamnionitis on the outcome of preterm infants. Am J Perinatol. 2013; 30:59–68.
Article
38. Eklind S, Mallard C, Leverin AL, Gilland E, Blomgren K, Mattsby-Baltzer I, et al. Bacterial endotoxin sensitizes the immature brain to hypoxic–ischaemic injury. Eur J Neurosci. 2001; 13:1101–6.
Article
39. Garnier Y, Coumans AB, Jensen A, Hasaart TH, Berger R. Infection-related perinatal brain injury: the pathogenic role of impaired fetal cardiovascular control. J Soc Gynecol Investig. 2003; 10:450–9.
Article
40. Kent A, Lomas F, Hurrion E, Dahlstrom JE. Antenatal steroids may reduce adverse neurological outcome following chorioamnionitis: Neurodevelopmental outcome and chorioamnionitis in premature infants. J Paediatr Child H. 2005; 41:186–90.
Article